📢 U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
📢 U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
Fri May 23 2025
·
json
·
rss
Subscribe:
RSS
JSON
About
Date: 2025-05-23T18:45:41
Source:
Web3Wire
Read more:
https://web3wire.org/web3/u-s-fda-approves-liquidias-yutrepia-treprostinil-inhalation-powder-for-patients-with-pulmonary-arterial-hypertension-pah-and-pulmonary-hypertension-associated-with-int/?utm_source=yeetum.com
